Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jan 6, 2026
144 Jan 6, 2026
144 Jan 6, 2026
144 Jan 6, 2026
144 Jan 6, 2026
144 Jan 5, 2026
144 Jan 5, 2026
144 Jan 5, 2026
144 Jan 5, 2026
144 Jan 5, 2026
424B5 Nov 13, 2025 424B5
10-Q Nov 12, 2025 10-Q
8-K Nov 12, 2025 8-K
4 Nov 10, 2025 FORM 4
3 Nov 10, 2025 FORM 3
8-K Nov 10, 2025 8-K
SCHEDULE 13G/A Nov 4, 2025
SCHEDULE 13G/A Aug 13, 2025
10-Q Aug 12, 2025 10-Q
8-K Aug 12, 2025 8-K
8-K Jul 15, 2025 8-K
4 Jun 5, 2025
4 Jun 5, 2025 FORM 4
4 Jun 5, 2025 FORM 4
4 Jun 5, 2025 FORM 4
← Newer Page 5 of 15 · 364 filings Older →